Other grades of this product :
| (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE Basic information |
| (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE Chemical Properties |
| Melting point | 148-152 °C(lit.) | | Boiling point | 508.0±50.0 °C(Predicted) | | density | 1.125±0.06 g/cm3(Predicted) | | solubility | 45% (w/v) aq 2-hydroxypropyl-β-cyclodextrin: >6.0 mg/mL | | pka | 13.88±0.20(Predicted) | | form | solid | | color | pale yellow | | optical activity | [α]25/D +16°, c = 1 in 1 M HCl |
| (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE Usage And Synthesis |
| Description | (+)-Atenolol is an enantiomer of the β1-adrenergic receptor (β1-AR) antagonist (±)-atenolol . (+)-Atenolol inhibits radioligand binding to β-ARs on sarcolemma-enriched membranes (Ki = 8.61 μM). Unlike (–)-atenolol and (±)-antenolol, (+)-atenolol has no effect on blood pressure in spontaneously hypertensive rats. | | Uses | Cardioselective β-adrenergic blocker. Antihypertensive, antianginal, antiarrhythmic (class II). | | Uses | Antihypertensor | | Uses | less active enantiomer | | Definition | ChEBI: The (R)-enantiomer of atenolol. | | references | [1] stoschitzky k, egginger g, zernig g, et al. stereoselective features of (r)- and (s)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies[j]. chirality, 1993, 5(1): 15-19. |
| (+)-4-[2-HYDROXY-3-[(1-METHYLETHYL)-AMINO]PROPOXY]BENZENEACETAMIDE Preparation Products And Raw materials |
|